Table 1.
Characteristics of the included studies on prevalence of headache among patients with epilepsy
| First author, date | Country | Sample size | Study design | Data collection tool | Prevalence (%) | Prevalence of any headache (%) | Prevalence (%) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | MA | MOA | TTH | IIH | PIH | ||||||
| Erin K, 2017 [34] | USA | 160 | Cross-sectional | Self-report | NA | NA | 40.00 | NA | ||||
| Singla et al., 2019 [35] | India | 123 | Cohort | Self-report | NA | NA | 47.10 | 21.10 | 26.00 | |||
| Sayena J et al., 2015 [36] | Iran | 150 | Cross-sectional | MSQ | NA | NA | 32.60 | 15.30 | 17.30 | |||
| Ashjazadeh N, 2015 [37] | Iran | 100 | Cross-sectional | ICHD-II | 48 | 52 | 54.00 | 15.00 | 39.00 | 42.53 | 31.48 | |
| Fattahzadeh AG et al., 2017 [38] | Iran | 900 | Cross-sectional | HIS | NA | NA | 85.20 | 27.90 | 48.20 | |||
| Ito M et al., 2004 [26] | Japan | 364 | Cross-sectional | ICHD-III | NA | NA | 40.40 | 26.00 | 50.00 | 40.40 | ||
| Inn-Chi L., 2018 [47] | Taiwan | 476 | Cross-sectional | ICHD-III | NA | NA | 9.70 | 9.70 | ||||
| Mainieri et al., 2015 [39] | Italy | 388 | Cross-sectional | ICHD-II | NA | NA | 53.90 | 26.30 | 19.10 | 48.50 | 19.10 | |
| Zhang et al., 2018 [37] | China | 339 | Cross-sectional | ICHD-III | 17 | 29 | 23.00 | 23.00 | ||||
| Gökhan Ö et al., 2010 [41] | Turkey | 86 | Cohort | Self-report | NA | NA | 47.60 | 13.90 | 12.80 | 16.30 | ||
| Mameniškiene R et al., 2016 [42] | Lithuania | 289 | Cross-sectional | HALT | 42 | 62 | 83.20 | 31.70 | 39.00 | 77.90 | ||
| Wang et al., 2014 [25] | China | 1109 | Cross-sectional | ICHD-II | 57 | 64 | 60.10 | 60.20 | 30.30 | 11.70 | 34.10 | |
| Slavica V. et al., 2012 [43] | Montenegro | 259 | Cross-sectional | ICDH II | 20 | 85 | 48.00 | 15.44 | 28.00 | |||
| Shamim R..,2018 [44] | Bangladesh | 376 | Cross-sectional | NA | NA | NA | 80.60 | NA | 80.60 | |||
| Kwan P et al., 2008 [38] | China | 227 | Cohort | HIT-6 | 68 | NA | 22.00 | 4.80 | 3.10 | 7.00 | 19.80 | |
| Yosria AHA. et al., 2017 [41] | Egypt | 118 | Case control | ICHD-III | 31 | 69 | 24.60 | 79.30 | ||||
| Sayed MA et al, 2019 [42] | Egypt | 100 | Cross-sectional | ICHD-III | 27 | 73 | 78.00 | 70.60 | 25.58 | 50.00 | 66.50 | |
Foot notes: MSQ Migraine Screening Questionnaire, ICHD-II The International Classification of Headache Disorders 2nd edition, ICHD-3 The International Classification of Headache Disorders 3rd edition, HALT The Headache-Attributed Lost Time, HIT-6 The six-item Headache Impact Test, IHS International Headache Society, MA migraine with aura, MOA Migraine without aura, TTH Tension type headache, PIH Post ictal headache, IIH Inter Ictal headache